Viewing Study NCT00048503


Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2025-12-26 @ 12:05 PM
Study NCT ID: NCT00048503
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2002-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module